Literature DB >> 10565009

Strategies for the design and delivery of antisense oligonucleotides in central nervous system.

W C Broaddus1, S S Prabhu, S Wu-Pong, G T Gillies, H Fillmore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10565009     DOI： 10.1016/s0076-6879(99)14099-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  3 in total

1.  Antisense oligonucleotide therapy for neurodegenerative disease.

Authors:  Richard A Smith; Timothy M Miller; Koji Yamanaka; Brett P Monia; Thomas P Condon; Gene Hung; Christian S Lobsiger; Chris M Ward; Melissa McAlonis-Downes; Hongbing Wei; Ed V Wancewicz; C Frank Bennett; Don W Cleveland
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

2.  Nanogels for oligonucleotide delivery to the brain.

Authors:  Serguei V Vinogradov; Elena V Batrakova; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2004 Jan-Feb       Impact factor: 4.774

3.  Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.

Authors:  Annelies Quaegebeur; Inmaculada Segura; Roberta Schmieder; Dries Verdegem; Ilaria Decimo; Francesco Bifari; Tom Dresselaers; Guy Eelen; Debapriva Ghosh; Shawn M Davidson; Sandra Schoors; Dorien Broekaert; Bert Cruys; Kristof Govaerts; Carla De Legher; Ann Bouché; Luc Schoonjans; Matt S Ramer; Gene Hung; Goele Bossaert; Don W Cleveland; Uwe Himmelreich; Thomas Voets; Robin Lemmens; C Frank Bennett; Wim Robberecht; Katrien De Bock; Mieke Dewerchin; Bart Ghesquière; Sarah-Maria Fendt; Peter Carmeliet
Journal:  Cell Metab       Date:  2016-01-07       Impact factor: 27.287
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.